Toxicogenomics. New perspectives for the molecular toxicology;Toksykogenomika. Nowe perspektywy toksykologii molekularnej

Medycyna Pracy

Volumn 55, Issue 2, 2004, Pages 193-202

  Lutz, Waldemar ^a,b   Kur, Barbara ^a,b  

^a Instytut Medycyny Pracy Prof J N   (Poland)

^b NONE   (Poland)

Author keywords

Toxicogenomics; Toxicoproteomics

Indexed keywords

BIOLOGICAL MARKER; TOXIC SUBSTANCE;

ASSAY; CARCINOGENESIS; CONCENTRATION (PARAMETERS); DISEASE PREDISPOSITION; DNA MICROARRAY; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; EVALUATION; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENOMICS; HISTOPATHOLOGY; HUMAN; LIVER TOXICITY; MEASUREMENT; MOLECULAR BIOLOGY; NEUROTOXICITY; OCCUPATIONAL EXPOSURE; REVIEW; SOMATIC CELL GENETICS; TECHNIQUE; TOXICITY;

EID: 2442505424     PISSN: 04655893     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Broder S., Venter J.C.: Sequencing the entire genomes of free-living organisms: The foundation of pharmacology in the new millennium. Annu. Rev. Pharmacol. Toxicol. 2000; 40: 97-132.
2. Ideker T., Galitski T., Hood L.: A new approach to decoding life: Systems biology. Annu. Rev. Genomics Hum. Genet. 2001; 2: 343-372.
3. Vanden Heuvel J.P.: Control of gene expression. W: Vanden Heuvel J.P., Perdew G.H., Mattes W.B., Greenlee W.F.[red.]. Comprehensive Toxicology. T. 14. Elsevier Science BV, New York 2002, ss. 57-79.
4. Corton Jch., Anderson S.P., Stauber A.J., Janszen D.B., Kimbell J.S., Conolly R.B.: Entering the era of toxicogenomics with DNA microarrays. CIIT. Activities. 1999; 19: 1-9.
5. Farr S., Dunn II R.T.: Concise review: gene expression applied to toxicology. Toxicol. Sci. 1999; 50: 1-9.
6. Fielden M.R., Zacharewski T.R.: Challenges and limitations of gene expression profilling in mechanistic and predictive toxicology. Toxicol. Sci. 2001; 60: 6-10.
7. Thomas R.S., Rank D.R., Penn S.G., Zastrow G.M., Hayes K.R., Pande K. i wsp.:: Identification of toxicologically predictive gene sets using cDNA microarrays. Mol. Pharmacol. 2001; 60: 1189-1194.
8. Vrana K.E.: Use of microarray technologies in toxicology research. Neurol. Toxicol. 2003; 24: 321-333.
9. Tugwood J.D., Hollins L.E., Cockerill M.J.: Genomics and the search for novel biomarkers in toxicology. Biomarkers 2003; 8: 79-92.
10. Ding X., Kaminsky L.S.: Human extrahepatic cytochromes P450: Function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 2003; 43: 149-173.
11. Waring J.F., Halbert D.N.: The promise of toxicogenomics. Curr. Opin. Mol. Therap. 2002; 4: 229-235.
12. Witzmann F.A., Bauer M.D., Fieno A.M.: Proteomic analysis of the renal effects of simulated occupational jet fuel exposure. Electrophoresis 2000; 21: 976-984.
13. Blackstock W.P., Weir M.P.: Proteomics: quantitative and physical mapping of cellular proteins. Trends. Biotechnol. 1999; 17: 121-127.
14. Gershon D.: Toxicogenomics gains impetus. Nature 2002; 415: 4-5.
15. Timbrell J.A.: Biomarkers in toxicology. Toxicology 1998; 129: 1-12.
16. Hamadeh H.K., Bushel P.R., Jayadev S., Martin K., DiSorbo O., Sieber S.i wsp.: Gene expression analysis reveals chemical-specific profiles. Toxcicol. Sci. 2002; 67: 219-231.
17. Pennie W.D.: Gene expression analysis in the microarray age. W: Vanden Heuvel J.P., Perdew G.H., Mattes W.B., Greenlee W.F. [red.]. Comprehensive Toxicology. T. 14. Elsevier Science BV, New York 2002, ss. 527-537.
18. Rockett J.C, Dix D.I.: DNA arrays: Technology, options and toxicological applications. Xenobiotica 2000; 30: 155-177.
19. Wang Y., Rea T., Blan J., Gray S., Sun Y.: Identification of the genes responsive to etoposide-induced apoptosis: Application of DNA chip technology. FEBS Lett. 1999; 445: 269-273.
20. Waring J.F., Jolly R.A., Ciurlionis R., Lum P.Y., Praestgaard J.T., Morfitt D.C. i wsp.: Clustering of heptotoxins based on mechanism of toxicity using gene expression profiles. Toxicol. Appl. Pharamacol. 2001; 175: 28-42.
21. Harris H.M., Fletcher S.T., Duggen C.M., Baker V.A.: The use of genomics technology to investigate gene expression changes in cultured human liver cells. Toxicol. In Vitro 2001; 15: 399-405.
22. Bartosiewicz M., Penn S., Buckpitt A.: Applications of gene arrays in environmental toxicology: Fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene and trichloroethylene. Environ. Health Perspect. 2001; 109: 71-74.
23. Bulera S.J., Eddy S.M., Ferguson E., Jatkoa T.A., Reindel J.F., Bleavins M.R.i wsp.: RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays. Hepatology 2001; 33: 1239-1258.
24. Ruepp S.U., Tonge R.P., Shaw J., Wallis N., Pognan F.: Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol. Sci. 2002; 65: 135-150.
25. Reilly T.P., Boundi M., Brady J.N., Plee-Masison C.A., Radonovich M.F., George J.W., Pohl L.R.: Expression profiling of acetaminophen liver toxicity in mice using microarray technology. Biochem. Biophys. Res. Commun. 2001; 282: 321-328.
26. Regunathan A., Glesne D.A., Wilson A.K., Song J., Nicolae D., Flores T., Bhattacharyya M.H.: Microarray analysis of changes in bone cell gene expression early after cadmium gavage in mice. Toxicol. Appl. Pharmacol. 2003; 191: 272-294.
27. Cheng R.Y.S., Zhao A., Alvord W.G., Powell D.A., Bare R.M., Masuda A., at al.: Gene expression dose-response changes in microarrays after exposure of human peripheral lung epithelial cells to nickel (II). Toxicol. Appl. Pharmacol. 2003; 191: 22-40.
28. Zawia N.H.: Transcriptional involvement in neurotoxicity. Toxicol. Appl. Pharmacol. 2003; 190: 177-189.
29. Pennie W.D., Tugwood J.D., Oliver G.J.A., Kimber I.: The principle and practice of toxicogenomics: applications and opportunities. Toxicol. Sci. 2000; 54: 277-283.
30. DeRisi J., Penland L., Brown P.O., Bittner M.L., Meltzer P.S., Ray M. i wsp.: Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature. Genetics. 1996; 14: 457-460.
31. Iacobuzio-Donahue C.A., Maitra A., Shen-Ong G.L., van Heek T., Ashfag R., Meyer R.: Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am. J. Pathol. 2002; 160: 1239-1246.
32. Vanacker J.M., Pettersson K., Gustafsson J.A., Laudet V.: Transcriptional targets shared by estrogen receptor-related receptors (ERRs) and estrogen receptor (ER) alpha, but not by ER beta. EMBO J. 1999; 18: 4270-4279.
33. Moller A., Soldan M., Volker U., Maser E.: Two-dimensional gel electrophoresis: a powerful method to elucidate cellular responses to toxic compounds. Toxicology 2001; 160: 129-138.
34. Kennedy S.: The role of proteomics in toxicology: Identification of biomarekrs of toxicity by protein expression analysis. Biomarkers 2002; 7: 269-290.
35. Witzmann F.A.: Proteomic applications in toxicology. W: Vanden Heuvel J.P., Perdew G.H., Mattes W.B., Greenlee W.F. [red.]. Comprehensive Toxicology. T. 14. Elsevier Science BV, New York 2002, ss. 539-558.
36. Schulz-Knappe P., Zucht H.D., Heine G., Jurgens M., Hess R., Schrader M.: Peptidometics: the comprehensive analysis of peptides in complex biological mixtures. Combin. Chem. High Throughput Screen. 2001; 4: 207-217.
37. Abraham R., Kelly J., Thibault P., Benchimol S.: Post-translational modification of p53 protein in response to ionizing radiation analyzed by mass spectrometry. J. Mol. Biol. 2000; 295: 853-864.
38. Apweiler R., Hermjakob H., Sharon N.: On the frquency of protein glycosylation, as deduced from analysis of the SWISS-Prot database. Biochem. Biophys. Acta 1999; 1437: 4-8.
39. Wilkins M.R., Gasteiger E., Gooley A.A., Herbert B.R., Molloy M.P., Binza P.A: High-throughput mass spectrometric discovery of protein post-translational modifications. J. Mol. Biol. 1999; 289: 645-657.
40. Gressner A.M.: Two-dimensional electrophoretic analysis of ribosomal proteins from chronically injured liver. J. Clin. Chem. Clin. Biochem. 1979; 17: 541-545.
41. Lemkin P., Lipkin L., Merril C.: Protein abnormalities inmacrophages bearing asbestos. Environ. Health Perspect. 1980; 34: 75-89.
42. Fountoulakis M., Berndt P., Boelsterli U.A: Two-dimensional database of mouse liver proteins: changes in hepatic protein levels following treatment with acetoaminophen or its nontoxic regioisomer 3-acetamidophenol. Electrophoresis 2000; 21: 2148-2161.
43. Aicher L., Wahl D., Arce A., Grenet O., Steiner S.: New insights into cyclosporine A nephrotoxicity by proteome analysis. Electrophoresis 1998; 19: 1998-2003.
44. Chen S., Cai L., Li X., Liu S.: Low-dose whole body irradiation induces alteration of protein in mouse splenocytes. Toxicol. Lett. 1999; 105: 141-152.
45. Pipkin J.L., Hinson W.G., Young J.F.,Rowland K.L., Shaddock J.G., Tolleson W.H.: Induction of stress proteins by electromagnetic fields in cultured HL-60 cells. Bioelectromagnetics 1999; 20: 347-357.
46. Weinreb O., van Boekel M.A., Dovart A.,Bloemendal H.: Effect of UV-A light on the chaperone-like properties of young and old lens alpha-crystallin. Invest. Ophtalmol. Vis. Sci. 2000; 41: 191-198.
47. Robertson D.G., Reily M.D.: Metabonomic technology as a tool for rapid throughput in vivo toxicity screening. W: Vanden Heuvel J.P., Perdew G.H., Mattes W.B., Greenlee W.F. [red.]. Comprehensive Toxicology. T. 14. Elsevier Science BV, New York 2002, ss. 583-610.
48. Smith L.: DNA microarrays and development. Hum. Mol. Genet. 2003; 12 (Supl. 1): 1-8.
49. Tennant R.W. The National Center for Toxicogenomics: Using new technologies to inform mechanistic toxicology. Environ. Health Perspect. 2002; 110: A8-A10.